GTx, Inc. (GTXI) Tops Q4 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to GTx, Inc. (GTXI) Tops Q4 EPS by 6c

GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2015 Financial Results

March 3, 2016 7:00 AM EST

-- Patient enrollment underway in two Phase 2 clinical trials of enobosarm for the treatment of advanced breast cancer; preliminary data from first stage of both trials expected by end of 2016 --

-- Lead SARD candidates have been selected for additional preclinical studies necessary to initiate first in human clinical trials --

-- Patient enrollment underway in Phase 2 proof-of-concept clinical trial of enobosarm in women with Stress Urinary Incontinence; anticipate top-line data in 2016 --

-- Conference call today at 9:00 a.m. Eastern Time --

... More